Seizing a Pap smear to catch a criminal? Ethical issues of forensic use of medical biobanks
By Nina de Groot,
Journal of Medical Ethics blog
| 06. 09. 2020
In our paper, we discuss pressing problems with respect to confidentiality, trust, autonomy and justice.
A couple of years ago, during my studies, I assisted with a surgical removal of a benign uterine tumor at a small local hospital. As not much else was happening that day, I decided to follow the tumor out of the operation room all the way down to the pathologist in the basement. After examining the tumor sample, the pathologist opened a couple of doors to the storage rooms. That’s when I found out about the huge archives of tissue material that comprised most of the tiny hospital’s basement. “Oh, but this is not everything”, the pathologist told me, “we keep most of the tissue samples in storage boxes next to the highway”. As the tissue sections were to be stored for 115 years, the archives were bursting at the seams.
Ever since, the vast amount of little human parts scattered across the country has fascinated me. In the years to follow, I would see dusty moving boxes in corridors, high-tech automatically operated storages, and tanks of liquid nitrogen in a hospital’s parking lot. Filled with blood, sperm, tumor samples...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By George Janes, BioNews | 04.20.2026
New regulations in sperm donation are being implemented by Belgium's Federal Agency for Medicines and Health Products (FAMHP), following revelations regarding the use of sperm carrying a cancer-causing mutation, and widespread breaches of donor limits.
In 2025, it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...